KR930017907A - β-락탐 화합물에 이용하기 위한 에스테르 절단방법 - Google Patents

β-락탐 화합물에 이용하기 위한 에스테르 절단방법 Download PDF

Info

Publication number
KR930017907A
KR930017907A KR1019930002043A KR930002043A KR930017907A KR 930017907 A KR930017907 A KR 930017907A KR 1019930002043 A KR1019930002043 A KR 1019930002043A KR 930002043 A KR930002043 A KR 930002043A KR 930017907 A KR930017907 A KR 930017907A
Authority
KR
South Korea
Prior art keywords
alkyl
substituted
group
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019930002043A
Other languages
English (en)
Korean (ko)
Inventor
웨인 피셔 잭
린 토마스 크리스티나
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR930017907A publication Critical patent/KR930017907A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02—Preparation
    • C07D463/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019930002043A 1992-02-18 1993-02-12 β-락탐 화합물에 이용하기 위한 에스테르 절단방법 Ceased KR930017907A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/836,640 US5302711A (en) 1992-02-18 1992-02-18 Ester cleavage process for use with β-lactams
US836,640 1992-02-18

Publications (1)

Publication Number Publication Date
KR930017907A true KR930017907A (ko) 1993-09-20

Family

ID=25272395

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930002043A Ceased KR930017907A (ko) 1992-02-18 1993-02-12 β-락탐 화합물에 이용하기 위한 에스테르 절단방법

Country Status (10)

Country Link
US (1) US5302711A (enExample)
EP (1) EP0557035A3 (enExample)
JP (1) JPH05286971A (enExample)
KR (1) KR930017907A (enExample)
BR (1) BR9300542A (enExample)
CA (1) CA2089540A1 (enExample)
HU (1) HUT64351A (enExample)
IL (1) IL104699A0 (enExample)
MX (1) MX9300761A (enExample)
TW (1) TW232694B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4100908B2 (ja) * 1999-07-30 2008-06-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 塩基性抗生物質・無機酸塩の製造法およびシュウ酸塩中間体
CN103588790A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 7-氨基-3-氯-3-头孢-4-羧酸-对硝基苄基酯的制备方法
CN106866704B (zh) * 2017-02-08 2019-06-14 河北科技大学 催化氢化脱除对硝基苄酯以制备7-acca的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1546757A (en) * 1975-04-10 1979-05-31 Lilly Industries Ltd Crystalline cephalosporin salts
JPS52106891A (en) * 1976-03-03 1977-09-07 Shionogi & Co Ltd Removal of carboxyl protecting group
DE2725519A1 (de) * 1977-06-06 1978-12-21 Shionogi & Co Verfahren zur herstellung freier carbonsaeuren durch esterspaltung
CA1218646A (en) * 1983-07-22 1987-03-03 Jack W. Fisher Deesterification to acids
DE3650526T2 (de) * 1985-08-12 1996-10-31 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
EP0263901A1 (en) * 1986-10-08 1988-04-20 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
EP0395219B1 (en) * 1989-03-30 1998-09-30 Pfizer Inc. Cephalosporins and their homologues, process for their preparation and pharmaceutical compositions
US5043439A (en) * 1990-03-08 1991-08-27 Bristol-Myers Squibb Company Process for production of cephalosporins
US5095107A (en) * 1990-11-05 1992-03-10 Eli Lilly And Company Process for cleavage of esters during the production of cephalosporins

Also Published As

Publication number Publication date
HUT64351A (en) 1993-12-28
BR9300542A (pt) 1993-08-24
EP0557035A2 (en) 1993-08-25
US5302711A (en) 1994-04-12
MX9300761A (es) 1993-09-01
TW232694B (enExample) 1994-10-21
IL104699A0 (en) 1993-06-10
EP0557035A3 (en) 1993-12-01
CA2089540A1 (en) 1993-08-19
HU9300384D0 (en) 1993-04-28
JPH05286971A (ja) 1993-11-02

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
HK5684A (en) Penicillin derivatives
IE802174L (en) Penicillin compounds
MY131501A (en) Process for the prepration of clavulanic acid
JPS559058A (en) 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
AU674839B2 (en) Pyridinecarboximidamide compound and use thereof
IE43840L (en) Clavulanic acid derivatives
HUT60924A (en) Process for producing composition in the form of emulsion or solution and comprising immunosuppressing compound
KR880012604A (ko) (1r,5s,6s )-2-치환 티오-6[(r)-1-히드록시에틸]-1-메틸-카바페넴-3-카복실산 유도체
ES8300774A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
IE891242L (en) Process for optically active 3-(methane-sulfonyloxy)thiolane¹and analogs
DE3381734D1 (de) Thiazolylessigsaeure-derivate und verfahren zu deren herstellung.
HK47993A (en) 7-beta-(2-(amino-4-thiazolyl)-2-alkenoylamino)-3-cephem-4-carboxylic acid ester derivatives
IE832310L (en) Vinylthioacetamido oxacephalosporin derivatives
IL99877A (en) Process for cleavage of esters during the production of cephalosporins
IE822917L (en) Optically active penems
DE3380024D1 (en) Process for the preparation of the 1'-ethoxycarbonyloxyethyl ester of benzylpenicillin
AU2307297A (en) Production of 7-aminocephalosporanic acid derivative
WO1993004059A1 (fr) Derive de 4-acylaminoimidazole
IE852246L (en) Penicillins
KR870006049A (ko) 1-카바세팔로스포린 항생물질의 제조 방법
AU565926B2 (en) 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives
DE3061435D1 (en) Process for the preparation of 5-(2,2,2,-trihalogen-ethyl)-dialkyl-tetrahydrofuran-2-ones
JPS5589257A (en) New easily-absorbable sulfur-containing prodrug of non- steroidal antiphlogistic, and their drug compositions
ES2002912A6 (es) Procedimiento para la produccion de antibioticos de cefalosporina

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930212

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980211

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930212

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19991129

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20000223

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19991129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I